The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD)
Por:
Allen NM, O'Rahelly M, Eymard B, Chouchane M, Hahn A, Kearns G, Kim DS, Byun SY, Nguyen CE, Schara-Schmidt U, Kölbel H, Della Marina A, Schneider-Gold C, Roefke K, Thieme A, Van den Bergh P, Avalos G, Álvarez-Velasco R, Natera-de Benito D, Cheng MHM, Chan WK, Wan HS, Thomas MA, Borch L, Lauzon J, Kornblum C, Reimann J, Mueller A, Kuntzer T, Norwood F, Ramdas S, Jacobson LW, Jie X, Fernandez-Garcia MA, Wraige E, Lim M, Lin JP, Claeys KG, Aktas S, Oskoui M, Hacohen Y, Masud A, Leite MI, Palace J, De Vivo D, Vincent A and Jungbluth H
Publicada:
3 oct 2023
Ahead of Print:
1 jun 2023
Resumen:
Allen et al. show that in utero exposure to maternal antibodies against the foetal AChR may mimic a wide range of persistent neuromuscular disorders in offspring, despite many asymptomatic mothers. Immune-based therapies during pregnancy can be preventative, while oral salbutamol is an effective treatment in offspring.
In utero exposure to maternal antibodies targeting the fetal acetylcholine receptor isoform (fAChR) can impair fetal movement, leading to arthrogryposis multiplex congenita (AMC). Fetal AChR antibodies have also been implicated in apparently rare, milder myopathic presentations termed fetal acetylcholine receptor inactivation syndrome (FARIS). The full spectrum associated with fAChR antibodies is still poorly understood. Moreover, since some mothers have no myasthenic symptoms, the condition is likely underreported, resulting in failure to implement effective preventive strategies. Here we report clinical and immunological data from a multicentre cohort (n = 46 cases) associated with maternal fAChR antibodies, including 29 novel and 17 previously reported with novel follow-up data. Remarkably, in 50% of mothers there was no previously established myasthenia gravis (MG) diagnosis. All mothers (n = 30) had AChR antibodies and, when tested, binding to fAChR was often much greater than that to the adult AChR isoform. Offspring death occurred in 11/46 (23.9%) cases, mainly antenatally due to termination of pregnancy prompted by severe AMC (7/46, 15.2%), or during early infancy, mainly from respiratory failure (4/46, 8.7%). Weakness, contractures, bulbar and respiratory involvement were prominent early in life, but improved gradually over time. Facial (25/34; 73.5%) and variable peripheral weakness (14/32; 43.8%), velopharyngeal insufficiency (18/24; 75%) and feeding difficulties (16/36; 44.4%) were the most common sequelae in long-term survivors. Other unexpected features included hearing loss (12/32; 37.5%), diaphragmatic paresis (5/35; 14.3%), CNS involvement (7/40; 17.5%) and pyloric stenosis (3/37; 8.1%). Oral salbutamol used empirically in 16/37 (43.2%) offspring resulted in symptom improvement in 13/16 (81.3%). Combining our series with all previously published cases, we identified 21/85 mothers treated with variable combinations of immunotherapies (corticosteroids/intravenous immunoglobulin/plasmapheresis) during pregnancy either for maternal MG symptom control (12/21 cases) or for fetal protection (9/21 cases). Compared to untreated pregnancies (64/85), maternal treatment resulted in a significant reduction in offspring deaths (P < 0.05) and other complications, with treatment approaches involving intravenous immunoglobulin/ plasmapheresis administered early in pregnancy most effective. We conclude that presentations due to in utero exposure to maternal (fetal) AChR antibodies are more common than currently recognized and may mimic a wide range of neuromuscular disorders. Considering the wide clinical spectrum and likely diversity of underlying mechanisms, we propose 'fetal acetylcholine receptor antibody-related disorders' (FARAD) as the most accurate term for these presentations. FARAD is vitally important to recognize, to institute appropriate management strategies for affected offspring and to improve outcomes in future pregnancies. Oral salbutamol is a symptomatic treatment option in survivors.
Filiaciones:
Allen NM:
Department of Paediatrics, University of Galway
Galway University Hospital, Galway, Ireland
Department of Paediatrics, School of Medicine, University of Galway, Galway H91 V4AY, Ireland
O'Rahelly M:
Department of Paediatrics, University of Galway
Galway University Hospital, Galway, Ireland
Department of Paediatrics, School of Medicine, University of Galway, Galway H91 V4AY, Ireland
Eymard B:
Centre de Référence, des maladies neuromusculaires Nord/Est/Ile-de-France, Unité Pathologie Neuromusculaire, Bâtiment Babinski, G.H. Pitie-Salpetriere, Paris, France
Centre de référence des maladies neuromusculaires Nord/Est/Ile-de-France, Unité Pathologie Neuromusculaire, Bâtiment Babinski, G.H. Pitie-Salpetriere, 75013 Paris, France
Chouchane M:
Department of Paediatrics, Centre Hospitalier Universitaire de Dijon, France
Department of Pediatrics, Centre Hospitalier Universitaire de Dijon, Dijon, France
Hahn A:
Department of Child Neurology, Giessen, Germany
Department of Child Neurology, University Hospital Giessen, 35392 Giessen, Germany
Kearns G:
Department of Maxillo-facial Surgery, St. James Hospital, Dublin, Ireland
Department of Maxillofacial Surgery, St. James Hospital, Dublin D08 NHY1, Ireland
Kim DS:
Department of Neurology, Pusan National University, School of Medicine, Pusan, South Korea
Department of Neurology, Pusan National University, School of Medicine, Pusan 50612, South Korea
Byun SY:
Department of Pediatrics, Pusan National University School of Medicine, Pusan, South Korea
Department of Pediatrics, Pusan National University, School of Medicine, Pusan 50612, South Korea
Nguyen CE:
Pediatric Neurology, CHU Sainte-Justine & Département de neurosciences, Université de Montréal, QC, Canada
Pediatric Neurology, CHU Sainte-Justine and Département de neurosciences, Université de Montréal, QC, H3T 1C5, Canada
Schara-Schmidt U:
Department of Pediatric Neurology, Centre for Translational Neuro- and Behavioral Sciences, University Duisburg-Essen, Germany
Department of Pediatric Neurology, Centre for Translational Neuro- and Behavioral Sciences, University Duisburg, Essen, DE-45147 Essen, Germany
Kölbel H:
Department of Pediatric Neurology, Centre for Translational Neuro- and Behavioral Sciences, University Duisburg-Essen, Germany
Department of Pediatric Neurology, Centre for Translational Neuro- and Behavioral Sciences, University Duisburg, Essen, DE-45147 Essen, Germany
Della Marina A:
Department of Pediatric Neurology, Centre for Translational Neuro- and Behavioral Sciences, University Duisburg-Essen, Germany
Schneider-Gold C:
Department of Neurology, St Josef Hospital, Ruhr-University Bochum, Bochum, Germany
Department of Neurology, St Josef Hospital, Ruhr-University Bochum, 44791 Bochum, Germany
Roefke K:
Klinik für Kinder- und Jugendmedizin, Erfurt, Germany
Klinik für Kinder- und Jugendmedizin, 99089 Erfurt, Germany
Thieme A:
Oberärztin Neurophysiologie, Klinik für Neurologie, klinische Neurophysiologie und Neurorehabilitation, St. Georg Klinikum, Eisenach, Germany
Department of Neurology, Clinical Neurophysiology and Neurorehabilitation, St. Georg Klinikum, 99817 Eisenach, Germany
Van den Bergh P:
Neuromuscular Reference Centre UCL St-Luc, University Hospital Saint-Luc, Brussels, Belgium
Neuromuscular Reference Centre UCL St-Luc, University Hospital Saint-Luc, 1200 Brussels, Belgium
Avalos G:
Department of Paediatrics, University of Galway
Galway University Hospital, Galway, Ireland
Department of Medicine, University of Galway, Galway H91 V4AY, Ireland
Álvarez-Velasco R:
Unitat Patologia Neuromuscular, Servei Neurologia Hospital Santa Creu i Sant Pau, Barcelona, Spain
Unitat Patologia Neuromuscular, Servei Neurologia Hospital Santa Creu i Sant Pau, 08025 Barcelona, Spain
Natera-de Benito D:
Neuromuscular Unit, Hospital Sant Joan de Déu, Barcelona, Spain
Neuromuscular Unit, Hospital Sant Joan de Déu, 08950 Barcelona, Spain
Cheng MHM:
Department of Paediatrics & Adolescent Medicine, Princess Margaret Hospital, Hong Kong
Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong
Chan WK:
Department of Paediatrics & Adolescent Medicine, Princess Margaret Hospital, Hong Kong
Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong
Wan HS:
Department of Paediatrics & Adolescent Medicine, Princess Margaret Hospital, Hong Kong
Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong
Thomas MA:
Department of Medical Genetics and Pediatrics, Cumming School of Medicine, University of Calgary, Alberta Children's Hospital, Calgary, Canada
Department of Medical Genetics and Pediatrics, Cumming School of Medicine, University of Calgary, Alberta Children's Hospital, Calgary, AB T3B 6A8, Canada
Borch L:
Department of Medical Genetics and Pediatrics, Cumming School of Medicine, University of Calgary, Alberta Children's Hospital, Calgary, Canada
Department of Medical Genetics and Pediatrics, Cumming School of Medicine, University of Calgary, Alberta Children's Hospital, Calgary, AB T3B 6A8, Canada
Lauzon J:
Department of Medical Genetics and Pediatrics, Cumming School of Medicine, University of Calgary, Alberta Children's Hospital, Calgary, Canada
Department of Medical Genetics and Pediatrics, Cumming School of Medicine, University of Calgary, Alberta Children's Hospital, Calgary, AB T3B 6A8, Canada
Kornblum C:
Department of Neurology, University Hospital Bonn, Germany
Center for Rare Diseases, University Hospital Bonn, Germany
Department of Neurology, University Hospital Bonn, 53127 Bonn, Germany
Center for Rare Diseases, University Hospital Bonn, 53127 Bonn, Germany
Reimann J:
Department of Neurology, University Hospital Bonn, Germany
Department of Neurology, University Hospital Bonn, 53127 Bonn, Germany
Mueller A:
Department of Neonatology and Pediatric Intensive Care, University Hospital, Bonn, Germany
Department of Neonatology and Pediatric Intensive Care, University Hospital Bonn, 53127, Bonn, Germany
Kuntzer T:
Nerve-muscle unit, Department of clinical neurosciences, CHUV, University of Lausanne, Switzerland
Nerve-Muscle Unit, Department of Clinical Neurosciences, CHUV, University of Lausanne, 1011 Lausanne, Switzerland
Norwood F:
Department of Neurology, King's College Hospital, London, UK
Department of Neurology, King's College Hospital, London SE5 9RS, UK
Ramdas S:
MDUK Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford, UK
MDUK Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK
Jacobson LW:
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford OX3 9DU, UK
Jie X:
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford OX3 9DU, UK
Fernandez-Garcia MA:
Department of Pediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, SE1 7EU, UK
Department of Children's Neurosciences, Evelina London Children's Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London SE1 7EH, UK
Wraige E:
Department of Pediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, SE1 7EU, UK
Department of Children's Neurosciences, Evelina London Children's Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London SE1 7EH, UK
Lim M:
Department of Pediatric Neurology, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, UK
Department of Children's Neurosciences, Evelina London Children's Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London SE1 7EH, UK
Department of Women and Children's Health, School of Life Course Sciences (SoLCS), King's College London, London SE1 9NH, UK
Lin JP:
Department of Pediatric Neurology, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, UK
Department of Children's Neurosciences, Evelina London Children's Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London SE1 7EH, UK
Claeys KG:
Department of Neurology, University Hospitals Leuven, 3000 Leuven, Belgium
Laboratory for Muscle Diseases and Neuropathies & Department of Neurosciences, KU Leuven, and Leuven Brain Institute (LBI), 3000 Leuven, Belgium
Laboratory for Muscle Diseases and Neuropathies, Department of Neurosciences, KU Leuven, and Leuven Brain Institute (LBI), 3000 Leuven, Belgium
Aktas S:
Acibadem University, Faculty of Medicine, Department of Pediatrics, Division of Neonatology, Istanbul, Turkey
Faculty of Medicine, Department of Pediatrics, Division of Neonatology, Acibadem University, 34752 Istanbul, Turkey
Oskoui M:
Department of Pediatrics, McGill University, Montreal, Canada
Department of Neurology and Neurosurgery, McGill University, Montreal, Canada
Centre for Outcomes Research and Evaluation, Research Institute McGill University Health Centre, Montreal, Canada
Department of Pediatrics, McGill University, Montreal, QC H4A 3J1, Canada
Department of Neurology and Neurosurgery, McGill University, Montreal, QC H4A 3J1, Canada
Centre for Outcomes Research and Evaluation, Research Institute McGill University Health Centre, Montreal, QC H3H 2R9, Canada
Hacohen Y:
Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK
Department of Neurology, Great Ormond Street Hospital for Children, London, UK
Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London WC1N 3BG, UK
Department of Neurology, Great Ormond Street Hospital for Children, London WC1N 3JH, UK
Masud A:
Departments of Neurology and Pediatrics, Columbia University Irving Medical Center, New York, NY, USA
Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032-3791, USA
Department of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032-3791, USA
Leite MI:
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford OX3 9DU, UK
Palace J:
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford OX3 9DU, UK
De Vivo D:
Departments of Neurology and Pediatrics, Columbia University Irving Medical Center, New York, NY, USA
Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032-3791, USA
Department of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032-3791, USA
Vincent A:
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford OX3 9DU, UK
Jungbluth H:
Department of Pediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, SE1 7EU, UK
Randall Centre for Cell and Molecular Biophysics, Muscle Signaling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London, UK
Department of Children's Neurosciences, Evelina London Children's Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London SE1 7EH, UK
Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London SE1 1YR, UK
Green Submitted, Green Accepted, hybrid
|